Security Snapshot

Ascendis Pharma A/S - Ordinary Shares (ASND) Institutional Ownership

CUSIP: K08588103

13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

300

Shares (Excl. Options)

65,840,737

Price

$266.72

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.02%
Share change
+54,076,789
Value change
+$14,422,436,019
Number of holders
300
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
62,714,857
SEC-reported price per share
$261.00
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ASND - Ascendis Pharma A/S - Ordinary Shares is tracked under CUSIP K08588103.
  • 300 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 8 to 300 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $1,815,328,317 to $17,560,230,957.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 300 institutions filings for Q2 2026.

Open SEC evidence

Security key

K08588103

Latest holder period

Q2 2026

13F holders

300

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
ASND
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Artisan Partners Limited Partnership 4.2% $698,595,845 2,634,024 Artisan Partners Asset Management Inc. 30 Jun 2026

As of 30 Jun 2026, 300 institutional investors reported holding 65,840,737 shares of Ascendis Pharma A/S - Ordinary Shares (ASND). This represents 105% of the company’s total 62,714,857 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
88%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RA CAPITAL MANAGEMENT, L.P. 16% 10,281,496 24% $2,742,280,613
T. Rowe Price Investment Management, Inc. 11% 6,754,846 +9.6% 1.2% $1,801,653,000
Avoro Capital Advisors LLC 8.1% 5,111,111 12% $1,363,235,526
WESTFIELD CAPITAL MANAGEMENT CO LP 7.7% 4,798,267 4.2% $1,279,793,795
Jupiter Topco LLC 5.8% 3,648,772 0% 0.4% $973,379,718
FMR LLC 5.7% 3,545,575 0.04% $945,675,893
Artisan Partners Limited Partnership 4.2% 2,634,024 1.1% $702,546,942
BlackRock, Inc. 3.5% 2,211,833 0.01% $589,940,098
Capital International Investors 3.2% 1,988,614 0.11% $530,403,126
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 3% 1,875,301 0.17% $500,141,116
FRANKLIN RESOURCES INC 3% 1,862,503 0.11% $496,766,746
WELLINGTON MANAGEMENT GROUP LLP 2.5% 1,548,636 0.07% $413,052,195
AMERICAN CENTURY COMPANIES INC 2.2% 1,400,575 0.17% $373,562,338
PERCEPTIVE ADVISORS LLC 1.9% 1,163,721 4.8% $310,387,665
PRICE T ROWE ASSOCIATES INC /MD/ 1.8% 1,122,529 -27% 0.03% $299,402,000
Capital World Investors 1.4% 906,081 0.03% $241,669,924
PRINCIPAL FINANCIAL GROUP INC 1.4% 873,502 0.11% $232,980,454
Polar Capital Holdings Plc 0.98% 616,908 0.47% $164,541,702
GOLDMAN SACHS GROUP INC 0.89% 559,534 0.02% $149,238,909
MORGAN STANLEY 0.87% 544,393 0.01% $145,200,813
Invesco Ltd. 0.66% 414,196 0.01% $110,474,356
GEODE CAPITAL MANAGEMENT, LLC 0.64% 403,151 0.01% $107,528,433
UBS Group AG 0.64% 401,881 0.02% $107,189,700
ALLIANCEBERNSTEIN L.P. 0.64% 399,292 0.04% $106,499,162
Vestal Point Capital, LP 0.6% 375,000 2.3% $100,020,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 65,840,737 $17,560,230,957 +$14,422,436,019 $266.72 300
2026 Q1 7,936,554 $1,815,328,317 +$1,815,328,317 $228.73 8
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .